Clinical-stage biopharmaceutical company developing precision therapies for cancer, especially GIST.[1][2][4]
Get notified the moment IDRx files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.